Recruiting |
MitraClip REPAIR MR Study
|
Recruiting |
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
- Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency, Cardiovascular Diseases, Valve Disease, Heart, Heart Valve Diseases, Functional Mitral Regurgitation, Degenerative Mitral Valve Disease
|
Recruiting |
Evaluating Auscul-X, a Touch Free Digital Stethoscope
- Interventions: Device Auscul-X
- Sponsor: AusculSciences Canada Inc., Ottawa Heart Institute Research Corporation
|
Recruiting |
Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Patients Undergoing Open-chest Cardiac Surgery (NOVA)
|
Recruiting |
Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients With AsYmptomatic Severe Aortic Stenosis
- Conditions: Aortic Stenosis, Heart Diseases
- Interventions: Device Edwards SAPIEN 3 / SAPIEN 3 Ultra THV
|
Recruiting |
A Study of ARRY-371797 in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
- Conditions: Dilated Cardiomyopathy, Lamin A/C Gene Mutation
|
Recruiting |
ILUMIEN IV: OPTIMAL PCI
- Conditions: Coronary Artery Disease, Coronary Stenosis, Atherosclerosis, STEMI, STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI
- Sponsor: Abbott Medical Devices, Abbott
|
Recruiting |
Randomization of Single vs Multiple Arterial Grafts
- Conditions: Coronary Artery Disease, Heart Diseases
- Sponsor: Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), Canadian Institutes of Health Research (CIHR)
|
Recruiting |
The Psychological, Social, and Economic Impacts of COVID-19
- Conditions: COVID-19, Chronic Disease, Psychiatric Disorder, Cardiovascular Diseases
- Interventions:
- Sponsor: University of Ottawa, Hopital du Sacre-Coeur de Montreal, Sunnybrook Health Sciences Centre, Southlake Regional Health Centre, The Ottawa Hospital Research Institute, Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, Centre for Addiction and Mental Health, CHEO Research Institute, Ottawa Heart Institute Research Corporation, McGill University, Johns Hopkins University, Université de Montréal, The Royal's Institute of Mental Health Research
|
Recruiting |
Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
|
Recruiting |
Sildenafil for the Prevention of Right Heart Failure Following LVAD Implantation
- Interventions: Drug Sildenafil Citrate
- Sponsor: University of Calgary, Pfizer
|
Recruiting |
Antiarrhythmics or Ablation for Ventricular Tachycardia 2
- Sponsor: John Sapp, Heart and Stroke Foundation of Canada, Abbott Medical Devices, Biosense Webster, Inc., Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Cardiac Arrhythmia Network of Canada, Abbott, Nova Scotia Health Authority
|
Recruiting |
TRILUMINATE Pivotal Trial
- Interventions: Device Tricuspid valve repair
|
Recruiting |
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome
|
Recruiting |
Effect of a Hybrid Rehabilitation Program on Walking, Quality of Life & Cardiovascular Risk in People With PAD
- Interventions: Behavioral HY-PAD
- Sponsor: Ottawa Heart Institute Research Corporation, AFP Innovation Fund
|
Recruiting |
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Conditions: Atrial Fibrillation, Stroke, Bleeding
- Sponsor: Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), Vanderbilt University Medical Center
|
Recruiting |
E-health Intervention for Cardiac Rehabilitation
- Conditions: Coronary Heart Disease, Valve Disease, Heart
|
Recruiting |
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
|
Recruiting |
Healing Hearts Together: Evaluating a Couples-based Intervention to Improve Health Outcomes
- Interventions: Other Healing Hearts Together
|
Recruiting |
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
- Interventions: Device On-X Aortic Heart Valve replacement
|
Recruiting |
Smartphone Assessment Prior Radial Artery Harvesting for CABG
|
Recruiting |
An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)
- Sponsor: GE Healthcare, Pharmaceutical Product Development, LLC
|
Recruiting |
Multi-Center Evaluation of Feasibility of SPECT Measurement of Myocardial Blood Flow and Reserve
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, GE Healthcare
|
Recruiting |
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
- Conditions: Heart Transplant Failure and Rejection, Heart Failure, Heart Diseases, Heart Failure,Congestive, Transplant, Failure, Heart, Transplant Failure
- Interventions:
- Sponsor: University of British Columbia, Canadian Institutes of Health Research (CIHR), PROOF Centre of Excellence, Duke University, University of Nebraska, Toronto General Hospital, St. Paul's Hospital, Canada
|
Recruiting |
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
- Conditions: Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
- Interventions: Procedure Thoracic Aortic Surgery
- Sponsor: Ottawa Heart Institute Research Corporation, University of Calgary
|
Recruiting |
Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation (Exercise-AF)
- Conditions:Persistent or Permanent Atrial Fibrillation (Exercise-AF)
- Interventions:Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.
Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.
|
Recruiting |
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- Interventions: Drug Rivaroxaban 15 MG Oral Tablet [Xarelto]
|
Recruiting |
Cardiac Sarcoidosis Randomized Trial
- Conditions: Cardiac Sarcoidosis, Sarcoidosis
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Early Post Transplant Cardiac Allograft Vasculopathy
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Toronto General Hospital
|
Recruiting |
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
- Sponsor: Ottawa Heart Institute Research Corporation, London Health Sciences Centre, Heart Center Leipzig - University Hospital, Fortis Escorts Heart Institute, The Methodist Hospital System, Carolinas Medical Center, Gundersen Lutheran Health System, Jilin Heart Hospital, Far Eastern Memorial Hospital, Medtronic, Apollo Hospitals, Ichinomiya-Nishi Hospital, Fresno Heart and Surgical Hospital
|
Recruiting |
Peer Support for Women With Heart Disease: Women@Heart
- Conditions: Coronary Heart Disease, Women's Health
- Interventions: Behavioral Women@Heart Program
|
Recruiting |
Thoraflex Hybrid Post-Market Study
- Conditions: Acute Aortic Dissection, Aortic Rupture, Penetrating Aortic Ulcer, Aortic Dissection, Aortic Aneurysm, Thoracic
- Interventions: Behavioral EQ-5D-5L QOL questionnaire
|
Recruiting |
Exercise Training in Patients With Persistent or Permanent Atrial Fibrillation
|
Recruiting |
Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation
- Interventions: Procedure Catheter ablation
- Sponsor: Ottawa Heart Institute Research Corporation, Heart and Stroke Foundation of Canada
|
Recruiting |
Biomarker Guided Discharge of Heart Failure Patients
- Interventions: Other Biomarker guided discharge algorithm
- Sponsor: Peter Liu, Genome Canada, Roche Diagnostics, Ottawa Heart Institute Research Corporation
|
Recruiting |
Avoid Transvenous Leads in Appropriate Subjects
- Interventions: Device Implantable Cardioverter Defibrillator
- Sponsor: Population Health Research Institute, Boston Scientific Corporation
|
Recruiting |
Sub-Clinical Atrial Fibrillation Biomarker Study
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Population Health Research Institute, Genome Canada, Bristol-Myers Squibb, Pfizer, Medtronic, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Detection of Atrial Fibrillation After Cardiac Surgery
- Conditions: Atrial Fibrillation, Atrial Flutter, C.Surgical Procedure, Cardiac, Arrhythmias, Cardiac
|
Recruiting |
Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs
- Sponsor: Northern Therapeutics, Ottawa Hospital Research Institute
|
Recruiting |
Personalized Dosing of Nicotine Replacement (NRT to Effect)
- Conditions: Tobacco Use Disorder, Nicotine Dependence
- Sponsor: Centre for Addiction and Mental Health, Canadian Cancer Society Research Institute (CCSRI), Ottawa Heart Institute Research Corporation
|
Recruiting |
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
- Sponsor: Boca Raton Regional Hospital, AstraZeneca, Ottawa Heart Institute Research Corporation
|
Recruiting |
Coronary Physiology and Its Relationship to Anatomy in Patients With Diabetes Mellitus
- Conditions: Diabetes Mellitus, Coronary Artery Disease
- Interventions: Device Pressure Wire Certus, St. Jude Medical, USA
|
Recruiting |
Mobilization of Endothelial Progenitor Cells and Aspirin
- Interventions: Drug Aspirin
|
Recruiting |
Timing of Coronary Artery Bypass Surgery Among Patients With Acute Coronary Syndromes Initially on Ticagrelor
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
- Conditions: Atrial Fibrillation, Stroke
- Sponsor: Population Health Research Institute, Bristol-Myers Squibb, Pfizer, Medtronic, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Multicenter Prospective Study of Low-Flow Low-Gradient Aortic Stenosis (TOPAS Study)
- Sponsor: Laval University, University Hospital, Brest
|
Recruiting |
Cardiac Sarcoidosis Multi-Center Prospective Cohort
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Ontario Ministry of Health and Long Term Care, Canadian Institutes of Health Research (CIHR)
|
Recruiting |
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
- Conditions: Sleep Apnea, Heart Failure
- Interventions: Device Adaptive Servo Ventilation
- Sponsor: Toronto Rehabilitation Institute, Canadian Institutes of Health Research (CIHR), Philips Respironics
|
Recruiting |
Cardiac FDG PET Viability Registry
- Conditions: Heart Failure, Ischemic Heart Disease, Myocardial Dysfunction
- Interventions:
- Sponsor: Ottawa Heart Institute Research Corporation, Ontario Ministry of Health and Long Term Care
|
Recruiting |
Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
- Conditions: Embolism and Thrombosis of the Radial Artery, Coronary Heart Disease
|
Recruiting |
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
- Conditions: Myocardial Infarction, Sudden Death
- Sponsor: University of Calgary, Canadian Institutes of Health Research (CIHR), Alberta Innovation and Science, Medtronic, GE Healthcare
|
Recruiting |
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
- Interventions: Other single photon emission computed tomography
- Sponsor: Ottawa Heart Institute Research Corporation, GE Healthcare
|
Recruiting |
Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
- Conditions: Atrial Fibrillation, Stroke
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR), Bayer, Biotronik Canada Inc
|
Recruiting |
ASV Effects on Myocardial Energetics and Sympathetic Nerve Function in Heart Failure and Sleep Apnea.
- Conditions: Heart Failure, Obstructive Sleep Apnea, Central Sleep Apnea
- Interventions: Other [C11]Acetate and HED PET
|
Recruiting |
PERIGON Pivotal Trial
- Interventions: Device Model 400 aortic valve bioprosthesis
- Sponsor: Medtronic Cardiovascular, Medtronic
|
Recruiting |
SodiUm SeleniTe Administration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
- Sponsor: Daren K. Heyland, biosyn Arzneimittel GmbH, Queen's University, RWTH Aachen University
|
Recruiting |
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
- Conditions: Heart Disease, Congestive Heart Failure, Atrial Fibrillation
- Sponsor: Ottawa Heart Institute Research Corporation, Canadian Institutes of Health Research (CIHR)
|